The problem has never been the efficacy of Penthrox, its always been the uptake from hospitals, ambos etc. That's our real problem.
I haven't heard anything from MVP about how they plan to deal with that problem either, perhaps because they outsource distribution and think that is good enough.
- Forums
- ASX - By Stock
- MVP
- Yet another favorable report
MVP
medical developments international limited
Add to My Watchlist
1.83%
!
55.5¢

Yet another favorable report, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
55.5¢ |
Change
0.010(1.83%) |
Mkt cap ! $61.39M |
Open | High | Low | Value | Volume |
55.5¢ | 55.5¢ | 55.5¢ | $10 | 18 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3304 | 54.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
55.5¢ | 4212 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3304 | 0.540 |
2 | 14308 | 0.535 |
2 | 1815 | 0.530 |
2 | 60884 | 0.525 |
1 | 1962 | 0.510 |
Price($) | Vol. | No. |
---|---|---|
0.555 | 4212 | 2 |
0.560 | 46046 | 3 |
0.570 | 1884 | 2 |
0.575 | 3384 | 2 |
0.580 | 1000 | 1 |
Last trade - 10.01am 02/07/2025 (20 minute delay) ? |
Featured News
MVP (ASX) Chart |
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Dr. Hartley Atkinson, MD
Dr. Hartley Atkinson
MD
Previous Video
Next Video
SPONSORED BY The Market Online